tiprankstipranks
Anavex Life Sciences (AVXL)
NASDAQ:AVXL
US Market
AVXL
Anavex Life Sciences
RESEARCH TOOLSreports

Anavex Life Sciences (AVXL) Income Statement

1,743 Followers

Anavex Life Sciences Income Statement

Last quarter (Q1 2026), Anavex Life Sciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, Anavex Life Sciences's net income was $-5.68M. See Anavex Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 25Sep 24Sep 23Sep 22Sep 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 51.41M$ 52.88M$ 55.76M$ 50.99M$ 42.00M
Depreciation and Amortization
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA
$ -46.38M$ -43.00M$ -46.54M$ -47.62M$ -37.64M
Operating Income
$ -51.41M$ -52.88M$ -55.76M$ -50.99M$ -42.00M
Other Income/Expenses
$ 5.03M$ 9.88M$ 8.26M$ 3.37M$ 4.36M
Pretax Income
$ -46.38M$ -43.00M$ -47.51M$ -47.62M$ -37.64M
Net Income
$ -46.38M$ -43.00M$ -47.51M$ -47.98M$ -37.91M
Per Share Metrics
Basic EPS
$ -0.54$ -0.52$ -0.60$ -0.62$ -0.54
Diluted EPS
$ -0.54$ -0.52$ -0.60$ -0.62$ -0.54
Weighted Average Shares Outstanding
 85.29M 83.47M 79.79M 76.91M 69.80M
Weighted Average Shares Outstanding (Diluted)
 85.29M 83.47M 79.79M 76.91M 69.80M
Currency in USD

Anavex Life Sciences Earnings and Revenue History